More severe atopic dermatitis and psoriasis are associated with a higher cumulative impact
on quality of life, multimorbidity and healthcare costs. Proactive, early intervention in those …

Atopic dermatitis (AD) is a common, chronic, inflammatory skin disease affecting Australians
of all ages, races, ethnicities, and social classes. Significant physical, psychosocial, and …

Introduction Dupilumab is an interleukin-4 (IL-4) receptor alpha antagonist indicated for the
treatment of moderate-to-severe atopic dermatitis (AD), which could be associated with …

Ethnopharmacological relevance Artemisia annua L. belongs to the Asteraceae family and
has a long history of clinical application in China. It has been widely used for centuries to …

Atopic dermatitis (AD) is a heterogeneous disease in terms of its phenotypical, barrier, and
immunological presentation. Emerging therapies are undoubtedly contributing to a new …

Background Response to abrocitinib treatment for moderate-to-severe atopic dermatitis (AD)
has not been evaluated across racial and ethnic subpopulations. Objective To assess the …

Background Guidance addressing atopic dermatitis (AD) management, last issued in 2012
by the American Academy of Allergy, Asthma and Immunology/American College of Allergy …

The role of the environment in allergic skin disease | Current Allergy and Asthma Reports Skip
to main content SpringerLink Account Menu Find a journal Publish with us Track your research …

Early intervention and active management of infant atopic eczema may play a crucial role in
limiting eczema severity and preventing the onset of immediate‐type food allergy. Eczema …

The objective of the study was to investigate the association between outdoor and indoor air
pollution sources and atopic eczema among preschool children in South Africa. A cross …